Advanced search
Publication Cover
Current Medical Research and Opinion Volume 37, 2021 - Issue 8
Submit an article Journal homepage
2,300
Views
6
CrossRef citations to date
0
Altmetric
Oncology

Use of PD-1 and PD-L1 inhibitors after first-line therapy in esophageal cancer patients in the US

Jason C. Allairea Generativity Health Economics and Outcomes Research, Durham, NC, USA;b Department of Psychology, North Carolina State University, Raleigh, NC, USA
,
Mark Balkc BeiGene, Ltd., Emeryville, CA, USA
,
Soraya Azmic BeiGene, Ltd., Emeryville, CA, USA
,
Heather L. Handlc BeiGene, Ltd., Emeryville, CA, USA
,
Keri Yangc BeiGene, Ltd., Emeryville, CA, USA
&
Gisoo Barnesc BeiGene, Ltd., Emeryville, CA, USACorrespondence[email protected]
Pages 1403-1407 | Received 12 Jan 2021, Accepted 10 May 2021, Published online: 03 Jun 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.